News | PET-MRI | May 23, 2019

Study Explores Magnetic Nanoparticles as Bimodal Imaging Agent for PET/MRI

French study uses MR Solutions’ cryogen-free 3T PET/MRI scanner to investigate promising improvements in imaging capabilities

Study Explores Magnetic Nanoparticles as Bimodal Imaging Agent for PET/MRI

Image courtesy of MR Solutions.

May 23, 2019 — Researchers from Bourgogne University in Dijon, France, showed that use of superparamagnetic iron oxide nanoparticles (NPs) using multimodal positron emission tomography/magnetic resonance imaging (PET/MRI) offers promising improvements in nuclear imaging capabilities. The paper is published in the American Chemical Society journal ACS Omega.1

Using an MR Solutions cryogen-free, 3 Tesla (3T) scanner with a PET clip on the sequential images were found to be highly beneficial providing high spatial resolution, high sensitivity and high technical maturity with a low radiation dose.

Prof. Nadine Millot, principal investigator on the study commented, “The combination of simultaneous MRI/PET imaging is very attractive because it allies the high resolution of MRI with the high sensitivity of PET to obtain accurate anatomical and quantitative information at the same time.” This pioneering imaging agent highlights activity in the liver, spleen, lungs and kidneys before being gradually excreted from the body, with no cytotoxicity observed.

This is the first successful grafting of PEG and MANOTA chelator on prefunctionalized iron oxide NPs synthesized under continuous hydrothermal conditions for bimodal PET/MRI imaging and shows the potential benefits.

For more information: www.pubs.acs.org

 

Reference

1. Thomas G., Boudon J., Maurizi L., et al. Innovative Magnetic Nanoparticles for PET/MRI Bimodal Imaging. ACS Omega, published online Feb. 5, 2019. https://doi.org/10.1021/acsomega.8b03283

Related Content

GE Healthcare and Theragnostics Partnering on PSMA PET/CT Imaging Agent
News | Prostate Cancer | October 16, 2019
GE Healthcare and Theragnostics have entered into a global commercial partnership for a new prostate-specific membrane...
ASNC Announces Multisocietal Cardiac Amyloidosis Imaging Consensus
News | Cardiac Imaging | September 09, 2019
September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along
A 3-D printed tungsten pre-clinical X-ray system collimator. 3D printed, additive manufacturing for medical imaging.

A 3-D printed tungsten pre-clinical X-ray system collimator. The tungsten alloy powder is printed into the form desired and is laser fused so it can be machined and finished. Previously, making collimators from Tungsten was labor intensive because it required working with sheets of the metal to create the collimator matrix. 

Feature | Medical 3-D Printing | September 04, 2019 | By Steve Jeffery
In ...
A SPECT nuclear scan of the heart to show perfusion defects in the myocardium due to coronary artery blockages or heart attack. The imaging uses the Mo-99 based medical imaging isotope Tc-99m. The U.S. government has created policy to move away from use of highly enriched uranium (HEU) to low-enriched uranium (LEU) for Mo-99 isotope production, but there is one hold out who has not yet converted before a 2020 deadline. Photo courtesy of Philips Healthcare.

A SPECT nuclear scan of the heart to show perfusion defects in the myocardium due to coronary artery blockages or heart attack. The imaging uses the Mo-99 based medical imaging isotope Tc-99m. The U.S. government has created policy to move away from use of highly enriched uranium (HEU) to low-enriched uranium (LEU) for Mo-99 isotope production, but there is one holdout who has not yet converted before a 2020 deadline. Photo courtesy of Philips Healthcare.

Feature | Nuclear Imaging | August 30, 2019 | Dave Fornell, Editor
In a surprising move, the National Institute for Radioelements (IRE) has applied for a new license to export highly e
University of Alabama at Birmingham Leading Production of Theranostic Radioisotope

Image courtesy of the University of Alabama at Birmingham

News | Radiopharmaceuticals and Tracers | August 29, 2019
The University of Alabama at Birmingham, in conjunction with researchers at the University of Wisconsin and Argonne...
United Imaging Announces First U.S. Clinical Installation of uExplorer Total-body PET/CT
News | PET-CT | August 15, 2019
United Imaging announced that its uExplorer total-body positron emission tomography/computed tomography (PET/CT) system...
ASRT Supports Radiopharmaceutical Reimbursement Bill
News | Radiopharmaceuticals and Tracers | August 02, 2019
The American Society of Radiologic Technologists (ASRT) announced its support for House Resolution (HR) 3772, a measure...
International Multidisciplinary Group Publishes Recommendations for Personalized HCC Treatment With Y90 TheraSphere
News | Interventional Radiology | July 31, 2019
New consensus recommendations for personalized treatment for hepatocellular carcinoma (HCC) with BTG’s TheraSphere have...
NorthStar Medical Radioisotopes Awarded $30 Million by U.S. Department of Energy
News | Radiopharmaceuticals and Tracers | July 26, 2019
NorthStar Medical Radioisotopes LLC has been awarded $15 million in a cooperative agreement with the U.S. Department of...